Union Korea Pharm Co., Ltd. (KOSDAQ:080720)

Union Korea Pharm Revenue

Union Korea Pharm had revenue of 5.94B KRW in the quarter ending June 30, 2026, a decrease of -41.44%. This brings the company's total for the last twelve months to 25.45B, down -40.07% year-over-year. In the year 2025, Union Korea Pharm had annual revenue of 36.38B, down -29.06%. That makes Union Korea Pharm the 34,037th largest company in the world by revenue and 2,177th in South Korea.

• Revenue (ttm): 25.45B
• Revenue Growth: -40.07%
• P/S Ratio: 0.77
• Revenue / Employee: 212.12M
• Employees: 120
• Market Cap: 19.70B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.38B	-14.90B	-29.06%
Dec 31, 2024	51.28B	-11.89B	-18.82%
Dec 31, 2023	63.17B	1.88B	3.06%
Dec 31, 2022	61.29B	12.99B	26.89%
Dec 31, 2021	48.30B	-2.08B	-4.12%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error